Two large real-world analyses presented at ACTRIMS Forum 2026 shed new light on the multiple sclerosis (MS) care continuum, from the complex and often prolonged road to diagnosis to the substantial ...
Early treatment of pediatric-onset relapsing-remitting multiple sclerosis (MS) with high-efficacy therapy (HET) is associated with substantially slower disability progression than treatment with ...
Hosted on MSN
PoNS therapy shows promise for MS gait deficits
NEWTOWN, Pa. - Helius Medical Technologies, Inc. (NASDAQ:HSDT), a neurotech company with a market capitalization of $3.84 million, announced significant findings from the PoNS Therapeutic Experience ...
Please provide your email address to receive an email when new articles are posted on . Adults with MS took home videos of themselves walking and uploaded them to a digital platform. Video taken in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results